Method
This is a retrospective study including fifteen patients operated on in our institution for mitral valve thrombosis between 2012 through 2014. Ten patients (66.7%) were operated on as emergent cases (within 24 h after admission) and five patients (33.3%) were elective (3-5 days after admission). Mean age was 45 years and 12 were females. All patients had a mechanical valve implanted in the mitral position; mean time between first and second intervention was 3.9 years [7 day-19 years]. Clinically 14 patients (93.3%) were in NYHA stage III-IV on admission, seven had pulmonary edema (46.7%) and 6 had hemodynamic instability (40%) necessitating inotropic support. Mean preoperative mitral gradient was 26.4 mmHg. All patients underwent a surgical procedure, consisting of valve replacement in 14 patients and thrombectomy in one case. Five patients had associated tricuspid annuloplasty.
Results
Six patients died postoperatively which represents a 40% mortality rate. This occurred mainly in patients with hemodynamic instability and NYHA class IV. Good results were achieved in patients with stable clinical status (NYHA class II-III) with no mortality in this group. All other patients were discharged after an uneventful postoperative course and no patients had recurrence of valve thrombosis at a mean follow up of 17 months.
Discussion/Conclusion
MVT is a serious complication with a dark spontaneous prognosis. It management should be as short as possible between diagnosis and intervention. In stable cases, surgery leads to good results with low morbi-mortality rates. In case of hemodynamic instability, other alternatives should be considered, including thrombolysis because operative morbidity and mortality remain high in these cases.
